Route of Administration:
FETROJA is a Antibiotic drug manufactured by Shionogi Inc and administered via the Intravenous route of administration. The J Code: J0699 is aligned to the drug FETROJA.
Fetroja is an antibacterial drug used to treat infections caused by Gram-negative bacteria, specifically in complicated urinary-tract infections. This medication is administered through intravenous infusion over the course of three hours. Fetroja was previously aligned to the HCPCS code J0693, which was discontinued in October 2021. The new HCPCS code for Fetroja is J0699. The Fetroja website can be found here: https://www.fetroja.com/.